Inventor · disambiguated record
Rajender Kamboj
Also filed as: KAMBOJ RAJENDER · KAMBOJ RAJENDER K · KAMBOJ RAJENDER KUMAR
113 granted patents·35 pending applications·693 citations·filing 1992–2022
99Inventor score
Top patents by PatentIndex Score
148 records- 0195US8466188B2Use of spiro-oxindole compounds as therapeutic agentsCHAFEEV MIKHAIL·Filed 2007·Granted Jun 18, 2013·63 cites·1 claims
- 0295US7700641B2Spiro-oxindole compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2006·Granted Apr 20, 2010·39 cites·41 claims
- 0395US7511018B2Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereofXENON PHARMACEUTICALS INC·Filed 2005·Granted Mar 31, 2009·27 cites·18 claims
- 0494US8030488B2Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2008·Granted Oct 4, 2011·34 cites·28 claims
- 0593US7767677B2Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitorsXENON PHARMACEUTICALS INC·Filed 2005·Granted Aug 3, 2010·34 cites·10 claims
- 0692US7799798B2Spiroheterocyclic compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2006·Granted Sep 21, 2010·26 cites·9 claims
- 0792US7592343B2Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitorsXENON PHARMACEUTICALS INC·Filed 2005·Granted Sep 22, 2009·22 cites·6 claims
- 0892US7335658B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Feb 26, 2008·59 cites·95 claims
- 0991US11952380B2Substituted bicyclic heterocyclic compounds as PRMT5 inhibitorsLUPIN LTD·Filed 2022·Granted Apr 9, 2024·3 cites·20 claims
- 1091US8106087B2Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2009·Granted Jan 31, 2012·19 cites·6 claims
- 1191US7547698B2Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)XENON PHARMACEUTICALS INC·Filed 2005·Granted Jun 16, 2009·18 cites·9 claims
- 1288US9073943B2Antiviral compounds with a dibenzooxaheterocycle moietyLUPIN LTD·Filed 2013·Granted Jul 7, 2015·8 cites·22 claims
- 1388US7777036B2Heterocyclic derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2005·Granted Aug 17, 2010·13 cites·9 claims
- 1486US8541457B2Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitorsFU JIANMIN·Filed 2006·Granted Sep 24, 2013·16 cites·4 claims
- 1586US8258160B2SCD1 inhibitors triazole and tetrazole compoundsDALES NATALIE·Filed 2007·Granted Sep 4, 2012·11 cites·17 claims
- 1686US7893206B2Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereofXENON PHARMACEUTICALS INC·Filed 2009·Granted Feb 22, 2011·5 cites·17 claims
- 1786US7514436B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Apr 7, 2009·22 cites·30 claims
- 1886US7456180B2Piperazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Nov 25, 2008·24 cites·25 claims
- 1985US9399638B2Substituted pyridine compounds as CRAC modulatorsLUPIN LTD·Filed 2013·Granted Jul 26, 2016·11 cites·11 claims
- 2085US7919484B2Combination therapyXENON PHARMACEUTICALS INC·Filed 2006·Granted Apr 5, 2011·10 cites·18 claims
- 2184US8338450B2Compounds as dipeptidyl peptidase IV (DPP IV) inhibitorsARORA SUDERSHAN·Filed 2008·Granted Dec 25, 2012·28 cites·23 claims
- 2283US9073942B2Antiviral compounds with a heterotricycle moietyLUPIN LTD·Filed 2013·Granted Jul 7, 2015·9 cites·23 claims
- 2383US8063084B2Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid levelsDALES NATALIE·Filed 2007·Granted Nov 22, 2011·6 cites·14 claims
- 2482US8507435B2Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereofGOLDBERG YIGAL·Filed 2012·Granted Aug 13, 2013·5 cites·12 claims
- 2581US9598391B2Substituted chroman compounds as calcium sensing receptor modulatorsLUPIN LTD·Filed 2015·Granted Mar 21, 2017·4 cites·14 claims
- 2681US8071603B2Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitorsKAMBOJ RAJENDER·Filed 2005·Granted Dec 6, 2011·10 cites·5 claims
- 2779US11459330B2Substituted bicyclic heterocyclic compounds as PRMT5 inhibitorsLUPIN LTD·Filed 2018·Granted Oct 4, 2022·3 cites·17 claims
- 2879US8946432B2Biaryl derivatives as nAChR modulatorsSINHA NEELIMA·Filed 2012·Granted Feb 3, 2015·4 cites·10 claims
- 2978US12391695B2PRMT5 inhibitorsLUPIN LTD·Filed 2020·Granted Aug 19, 2025·1 cites·11 claims
- 3078US9987249B2Substituted chroman compounds as calcium sensing receptor modulatorsLUPIN ATLANTIS HOLDINGS SA·Filed 2017·Granted Jun 5, 2018·3 cites·15 claims
- 3178US9163001B2Substituted chroman compounds as calcium sensing receptor modulatorsLUPIN LTD·Filed 2013·Granted Oct 20, 2015·4 cites·29 claims
- 3278US8501746B2Organic compoundsDALES NATALIE·Filed 2007·Granted Aug 6, 2013·3 cites·16 claims
- 3378US8148378B2Pyridazine derivatives and their use as inhibitors of stearoyl-CoA desaturase-1 activity in a mammalGSCHWEND HEINZ W·Filed 2009·Granted Apr 3, 2012·5 cites·29 claims
- 3478US8026360B2Substituted pyridazines as stearoyl-CoA desaturase inhibitorsXENON PHARMACEUTICALS INC·Filed 2009·Granted Sep 27, 2011·3 cites·5 claims
- 3577US9555035B2Heterocyclyl compounds as MEK inhibitorsLUPIN LTD·Filed 2016·Granted Jan 31, 2017·2 cites·42 claims
- 3677US9393247B2Heteroaryl derivatives as alpha7 nAChR modulatorsLUPIN LTD·Filed 2015·Granted Jul 19, 2016·3 cites·22 claims
- 3775US7754711B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2005·Granted Jul 13, 2010·2 cites·6 claims
- 3875US5830712ASelective template deletion methodALLELIX BIOPHARMA·Filed 1996·Granted Nov 3, 1998·67 cites·3 claims
- 3974US12435066B2Substituted tricyclic compoundsLUPIN LTD·Filed 2020·Granted Oct 7, 2025·1 cites·27 claims
- 4073US9428499B2Heterocyclyl compounds as MEK inhibitorsLUPIN LTD·Filed 2013·Granted Aug 30, 2016·2 cites·28 claims
- 4173US9382216B2Substituted morpholines as modulators for the calcium sensing receptorSHUKLA MANOJKUMAR RAMPRASAD·Filed 2012·Granted Jul 5, 2016·2 cites·11 claims
- 4273US8252578B2Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereofGOLDBERG YIGAL P·Filed 2011·Granted Aug 28, 2012·1 cites·16 claims
- 4372US9227919B2Arylalkylamine compounds as calcium sensing receptor modulatorsLUPIN LTD·Filed 2013·Granted Jan 5, 2016·2 cites·16 claims
- 4472US9072731B2Heteroaryl derivatives as alpha7 nAChR modulatorsSINHA NEELIMA·Filed 2012·Granted Jul 7, 2015·3 cites·39 claims
- 4572US7919496B2Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymesXENON PHARMACEUTICALS INC·Filed 2005·Granted Apr 5, 2011·1 cites·10 claims
- 4671US9359367B2Tetrahydroquinazolinone derivatives as PARP inhibitorsLUPIN LTD·Filed 2013·Granted Jun 7, 2016·3 cites·19 claims
- 4771US7829712B2Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturaseXENON PHARMACEUTICALS INC·Filed 2005·Granted Nov 9, 2010·1 cites·16 claims
- 4869US9737534B2Oxazoline and isoxazoline derivatives as CRAC modulatorsLUPIN LTD·Filed 2015·Granted Aug 22, 2017·1 cites·8 claims
- 4967US7763618B2Pyridyl derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Jul 27, 2010·2 cites·43 claims
- 5065US9493396B2Substituted naphthalene compounds as calcium sensing receptor modulatorsLUPIN ATLANTIS HOLDINGS SA·Filed 2014·Granted Nov 15, 2016·1 cites·18 claims
Showing the top 50 of 148 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →